73 reports

  • 4.1 CATALYST

Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint' s cartilage and bone hypertrophy.

  • Orthopedics
  • Anika Therapeutics, Inc.
  • Ferring International Center S.A.
  • Sanofi S.A.
  • Seikagaku Corporation
  • 1.3 Hip

Though this disease is thought to have a genetic component, it is not known yet as to what specifically causes it.

  • Orthopedics
  • Johnson & Johnson
  • Smith & Nephew Plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • GLOBAL ORTHOBIOLOGICS MARKET BY BONE MORPHOGENETIC PROTEINS 2015-2020 ($ MILLIONS)
  • GLOBAL ORTHOBIOLOGICS MARKET BY BONE MORPHOGENETIC PROTEINS

These proteins, produced through genetic engineering, can help in bone healing.

  • Orthopedics
  • DePuy Synthes, Inc.
  • Medtronic, Inc.
  • Sanofi S.A.
  • Stryker Corporation
  • MARKET DRIVERS

These proteins, which are produced through genetic engineering, help with bone healing.

  • Orthopedics
  • Japan
  • DePuy Synthes, Inc.
  • Medtronic, Inc.
  • Smith & Nephew Plc
  • 4.1 CATALYST

Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint' s cartilage and bone hypertrophy.

  • Orthopedics
  • South America
  • Anika Therapeutics, Inc.
  • Ferring International Center S.A.
  • Sanofi S.A.
  • 4.1 CATALYST

Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint' s cartilage and bone hypertrophy.

  • Medical Device
  • Orthopedics
  • Ferring International Center S.A.
  • Sanofi S.A.
  • Seikagaku Corporation
  • 4.1 CATALYST

Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint' s cartilage and bone hypertrophy.

  • Orthopedics
  • North America
  • Anika Therapeutics, Inc.
  • Sanofi S.A.
  • Seikagaku Corporation
  • 4.1 CATALYST

Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint' s cartilage and bone hypertrophy.

  • Orthopedics
  • Europe
  • Forecast
  • Anika Therapeutics, Inc.
  • Sanofi S.A.

This extrapolation calculation is automated and does not take into account any genetic, cultural, environmental, social, racial or other differences across the various countries and regions for which the extrapolated Sports Injuries statistics refer to.

  • Orthopedics
  • World
  • Demand
  • Forecast
  • Market Size
  • KEY MARKET HIGHLIGHTS

It is a tissue-engineered product, which received orphan drug designation in Europe and the US for osteogenesis imperfecta, a genetic disorder that leads to bone fragility.

  • Orthopedics
  • Forecast
  • DePuy Synthes, Inc.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • KEY MARKET HIGHLIGHTS

It is a tissue-engineered product, which received orphan drug designation in Europe and the US for osteogenesis imperfecta, a genetic disorder, which leads to bone fragility.

  • Orthopedics
  • DePuy Synthes, Inc.
  • Stryker Corporation
  • Wright Medical Group
  • Zimmer Biomet Holdings, Inc.

Allograft bone chips are the transplanted bones, sourced from a genetically non-identical living or dead member of the same species.

  • Orthopedics
  • Japan
  • CollPlant
  • Medtronic, Inc.
  • Seikagaku Corporation

Allograft bone chips are the transplanted bones, sourced from a genetically non-identical living or dead member of the same species.

  • Orthopedics
  • Asia
  • Market Size
  • Arthrex, Inc.
  • Baxter International Inc.

Allograft bone chips are the transplanted bones, sourced from a genetically non-identical living or dead member of the same species.

  • Orthopedics
  • United Kingdom
  • Anika Therapeutics, Inc.
  • CollPlant
  • Medtronic, Inc.

CU Saint-Luc is known for having performed the first transplantation ever of ovarian tissue between genetically distinct sisters, in 2007, with consequential restoration of the ovaries' function and embryo development.

  • Healthcare
  • Hospital
  • Orthopedics
  • Belgium
  • TforG Group

CU Saint-Luc is known for having performed the first transplantation ever of ovarian tissue between genetically distinct sisters, in 2007, with consequential restoration of the ovaries' function and embryo development.

  • Healthcare
  • Hospital
  • Orthopedics
  • Belgium
  • TforG Group
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

A nonsense mutation is an alteration in the genetic code that prematurely halts the synthesis of an essential protein.

  • Orthopedics
  • Australia
  • Oceania
  • Forecast
  • Market Size

Developments in technology, insight into genetic factors and research into new treatment methods will make it possible to manage diseases in more efficient and cost effective ways, adding to the financial sustainability of the Dutch healthcare system.

  • Healthcare
  • Hospital
  • Orthopedics
  • Netherlands
  • TforG Group

Developments in technology, insight into genetic factors and research into new treatment methods will make it possible to manage diseases in more efficient and cost effective ways, adding to the financial sustainability of the Dutch healthcare system.

  • Healthcare
  • Hospital
  • Orthopedics
  • Netherlands
  • TforG Group

All of these products have the ability to help fracture re-growth using genetic engineering.

  • Orthopedics
  • Arthrex, Inc.
  • CONMED Corporation
  • DePuy Mitek, Inc.
  • DePuy Synthes, Inc.

Allograft bone chips are the transplanted bones, sourced from a genetically non-identical living or dead member of the same species.

  • Orthopedics
  • Asia
  • Market Size
  • Arthrex, Inc.
  • Bioventus LLC
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

Allograft bone chips are the transplanted bones, sourced from a genetically non-identical living or dead member of the same species.

  • Orthopedics
  • Europe
  • United Kingdom
  • Forecast
  • Market Size
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

Allograft bone chips are the transplanted bones, sourced from a genetically non-identical living or dead member of the same species.

  • Orthopedics
  • Europe
  • Russian Federation
  • Forecast
  • Market Size
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

Allograft bone chips are the transplanted bones, sourced from a genetically non-identical living or dead member of the same species.

  • Orthopedics
  • Mexico
  • North America
  • Forecast
  • Market Size
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

Allograft bone chips are the transplanted bones, sourced from a genetically non-identical living or dead member of the same species.

  • Orthopedics
  • Asia
  • South Korea
  • Forecast
  • Market Size
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

Allograft bone chips are the transplanted bones, sourced from a genetically non-identical living or dead member of the same species.

  • Orthopedics
  • Brazil
  • South America
  • Forecast
  • Market Size
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

Allograft bone chips are the transplanted bones, sourced from a genetically non-identical living or dead member of the same species.

  • Orthopedics
  • Asia
  • Japan
  • Forecast
  • Market Size
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

Allograft bone chips are the transplanted bones, sourced from a genetically non-identical living or dead member of the same species.

  • Orthopedics
  • Europe
  • Germany
  • Forecast
  • Market Size
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

Allograft bone chips are the transplanted bones, sourced from a genetically non-identical living or dead member of the same species.

  • Orthopedics
  • Asia
  • India
  • Forecast
  • Market Size
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

Allograft bone chips are the transplanted bones, sourced from a genetically non-identical living or dead member of the same species.

  • Orthopedics
  • Europe
  • Italy
  • Forecast
  • Market Size